Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 26-Oct 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2202221000001113 | Brexucabtagene autoleucel | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2212531000001110 | Brexucabtagene autoleucel (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brexucabtagene autoleucel | Is a | Genetically modified T-cell | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags | Has specific active ingredient | False | Brexucabtagene autoleucel | Inferred relationship | Existential restriction modifier | |
| Tecartus 40million-200million cells/68ml dispersion for infusion bags (Gilead Sciences Ltd) | Has specific active ingredient | False | Brexucabtagene autoleucel | Inferred relationship | Existential restriction modifier | |
| Tecartus 40million-200million cells/68ml dispersion for infusion bags (Gilead Sciences Ltd) 1 bag | Has specific active ingredient | False | Brexucabtagene autoleucel | Inferred relationship | Existential restriction modifier | |
| Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags 1 bag | Has specific active ingredient | False | Brexucabtagene autoleucel | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR